Multi-event December 2014 FDA Recall Drug by Walgreens Infusion Services

This Multi-event Class II drug recall was voluntarily initiated by Walgreens Infusion Services on December 26, 2014 for the product Drug. The FDA reported the reason for recall as lack of sterility assurance.. The product was distributed in Texas, Florida, Virginia, Georgia, Louisiana, Mississippi and the recall is currently terminated.

Reported Recall Events

D-0375-2015 TERMINATED D-0344-2015 TERMINATED D-0353-2015 TERMINATED D-0350-2015 TERMINATED D-0356-2015 TERMINATED D-0346-2015 TERMINATED D-0340-2015 TERMINATED D-0352-2015 TERMINATED D-0363-2015 TERMINATED D-0341-2015 TERMINATED D-0359-2015 TERMINATED D-0371-2015 TERMINATED D-0354-2015 TERMINATED D-0362-2015 TERMINATED D-0361-2015 TERMINATED D-0348-2015 TERMINATED D-0366-2015 TERMINATED D-0364-2015 TERMINATED D-0360-2015 TERMINATED D-0369-2015 TERMINATED D-0355-2015 TERMINATED D-0342-2015 TERMINATED D-0367-2015 TERMINATED D-0365-2015 TERMINATED D-0345-2015 TERMINATED D-0347-2015 TERMINATED D-0351-2015 TERMINATED D-0370-2015 TERMINATED D-0349-2015 TERMINATED D-0372-2015 TERMINATED D-0357-2015 TERMINATED D-0373-2015 TERMINATED D-0374-2015 TERMINATED D-0368-2015 TERMINATED D-0358-2015 TERMINATED D-0343-2015 TERMINATED

Recall Number: D-0375-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Total parenteral nutrition various strengths

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0344-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Cefoxitin various strength in normal saline bags

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0353-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Cefazolin various strengths in normal saline bags

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0350-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Cefuroxime various strengths in normal saline bags

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0356-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Daptomycin various strengths in normal saline bags

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0346-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Imipenem/ cilastatin various strength in normal saline bags

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0340-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Liposomal Amphotericin B 130 mg in dextrose bags

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0352-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Nafcillin various strengths in sterile water for injection bags

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0363-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Caspofungin various strengths in normal saline

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0341-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Amikacin various strength in normal saline bags

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0359-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Linezolid various strengths in dextrose

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0371-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Dehydrated alcohol vials

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0354-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Tobramycin various strengths in normal saline bags

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0362-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Milrinone various strengths in dextrose

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0361-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Acyclovir various strengths in normal saline

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0348-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Piperacillin/ tazobactam various strength in normal saline bags

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0366-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Folic acid 1 mg/ 0.2 ml pre-drawn syringes

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0364-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Dobutamine various strengths in dextrose

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0360-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Tigecycline various strengths in normal saline

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0369-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Magnesium sulfate various strengths in sodium chloride

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0355-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Gentamicin various strength in normal saline bags

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0342-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Aztreonam 1 gram in normal saline

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0367-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Thiamine 100 mg/ ml vials

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0365-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Dopamine various strengths in dextrose

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0345-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Ceftazidime various strength in normal saline bags

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0347-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Ertapenem various strength in normal saline bags

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0351-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Meropenem various strengths in normal saline bags

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0370-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Deferoxamine various strengths in normal saline

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0349-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Vancomycin various strengths in normal saline bags

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0372-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Diphenhydramine 50 mg/ml vials

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0357-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Ceftriaxone various strengths in normal saline

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0373-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Immune globulin g human various strengths

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0374-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
L-cysteine various strengths

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0368-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Ranitidine various strengths in syringes

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0358-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Levofloxacin various strengths in normal saline

Batch or Lot Expiration Information

Lot# All products within expiry.

Recall Number: D-0343-2015

Reason for Recall
Lack of sterility assurance.
Initiated
12-26-2014
Reported
01-28-2015
Quantity
N/A

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
70118
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Walgreens Infusion Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-24-2015
Product Description About Product Description
Full technical description of the product.
Cefepime various strengths in normal saline

Batch or Lot Expiration Information

Lot# All products within expiry.